Mixed drug toxicity (gabapentin, codeine, diazepam, oxycodone, doxylamine, promethazine, zolpidem) with contributing factor of cardiac hypertrophy
AI-generated summary
A 29-year-old man died from mixed drug toxicity involving multiple CNS depressants. His GP, Dr X, had maintained an inappropriate three-year sexual relationship with the patient while prescribing escalating doses of opioids, benzodiazepines, and other drugs of dependence without therapeutic justification. Medications were prescribed to facilitate sexual acts, in response to non-clinical requests via personal messages, and in excessive quantities without SafeScript compliance or Schedule 8 permits. The second GP, Dr Y, continued this inappropriate regime without adequate handover or independent clinical assessment. The coroner found the death preventable, attributing it to Dr X's material departure from professional standards through inappropriate prescribing driven by a sexual relationship with his patient. Key clinical lessons include the critical importance of maintaining professional boundaries, implementing proper medication safety measures for polypharmacy patients, and ensuring adequate clinical handover between practitioners.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
drug dependenceopioid use disorderbenzodiazepine dependencegeneralized anxiety disorderinsomniachronic back paincardiac hypertrophypolypharmacy
Contributing factors
inappropriate prescribing of drugs of dependence
sexual relationship between doctor and patient
lack of SafeScript compliance
absence of Schedule 8 permits
excessive quantities of CNS depressants prescribed
inadequate medication safety measures for polypharmacy
lack of therapeutic justification for prescriptions
prescribing medications to facilitate sexual acts
poor handover between practitioners
cardiac hypertrophy
drug dependence
Coroner's recommendations
Refer Dr X and Dr Y to Ahpra for investigation and consideration of disciplinary action
Enhance compliance and oversight of SafeScript requirements, including developing additional strategies with the Royal Australian College of General Practitioners, Medical Board of Australia and Pharmacy Board of Australia
Develop education and training tools for clinicians regarding proper use of real-time prescription monitoring systems
Ensure clear protocols for adequate handovers between practitioners, particularly in multi-practitioner practices
Implement staged supply arrangements and medication safety measures for polypharmacy patients on CNS depressants and drugs of dependence
Strengthen training on professional boundaries and the risks of sexual relationships with patients, particularly for practitioners serving vulnerable populations including LGBTIQA+ patients
Establish clearer compliance auditing mechanisms for SafeScript and Schedule 8 permit requirements
Promote the use of doctors' health services and peer consultation when clinicians are uncertain about clinical practices
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.